Home / Resources / Lost in translation: “Smart early clinical development with the end in mind” Part 2
17 May 23
By Judit Molnar
Back by popular demand, do not miss out on this sold-out event. Lost in translation will address efficiently progressing innovative medicines from research into pre-clinical and first-in-man studies is important in maximising value creation in any biotech or Pharma company. That progress however must be based on robust studies to increase the probability of success. This BioWednesday event, led by tranScrip discusses how investors and entrepreneurs evaluate small companies for investment. We will give you hints and tips to take away that will help inform your critical decisions. We will explore how companies managed to navigate the hurdles towards the clinic, what made the difference, pain points, and bugbears.
Complete the form below to access this content. Do you have an early development project coming up?
Get in touch with us to see how we can help.
Fields marked with * are required
Drug development in many areas of internal medicine is thriving, with companies expanding their pipelines...
We have teams of life science and R&D experts to help achieve your goals and seize opportunities.
Whatever your project requires, we have the people to meet your needs.